Faktor risiko dan tatalaksana kandidiasis oral pada pasien dengan drug reaction with eosinophilia and systemic symptoms (DRESS)
Risk factors and management of oral candidiasis in drug reaction with eosinophilia and systemic symptoms (DRESS) patients
Abstract
Pendahuluan: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) adalah reaksi obat yang jarang terjadi, tetapi menimbulkan reaksi klinis yang berat, berupa demam, erupsi kulit, dan keterlibatan organ internal. Terapi medikasi untuk pasien DRESS berupa pemberian kortikosteroid high potent memiliki faktor risiko terjadinya kandidiasis oral selain faktor gangguan imunitas secara sistemik akibat DRESS. Penulisan laporan kasus bertujuan untuk memaparkan faktor risiko dan tatalaksana kandidiasis oral pada pasien DRESS. Laporan kasus: Seorang laki-laki berusia 51 tahun dirawat selama 14 hari dengan diagnosis DRESS oleh bagian Dermatologi dan Venereologi Rumah Sakit Hasan Sadikin Bandung. Terapi intravena yang diberikan adalah Deksametason 20 gram/hari, Vitamin K 3x1 ampul/hari, Omeprazole 1x40 gram/hari, dan Siprofloksasin 2x400 gram/hari. Terapi per oral yang diberikan adalah: Cetirizine 1x10 gram/hari, Curcuma 3x1 kapsul/hari, Asam folat 1x1 tab/hari, Asetilsistein 2x2 mg/hari, serta Callos 1x500 mg/hari. Pasien kemudian dikonsulkan ke bagian Ilmu Penyakit Mulut karena memiliki keluhan sakit pada rongga mulut, tenggorokan, dan bibir sejak 3 hari di RS. Riwayat sariawan berulang disangkal. Pasien tidak pernah menyikat gigi selama rawat inap. Tatalaksana kandidiasis oral diberikan Nystatin in oral suspension 4x200.000 IU/hari, Chlorhexidine digluconate 0,12%, asam hialuronat, NaCl 0,9%, serta Mikonazol krim 2% dan racikan deksametason salep 0,002% diberikan terkait lesi pada bibir dan dioleskan pada sudut mulut. Simpulan: Faktor risiko kandidiasis oral pada pasien DRESS adalah penggunaan kortikosteroid secara sistemik, gangguan imun terkait DRESS, dan kebersihan rongga mulut yang buruk. Tatalaksana kandidiasis oral diberikan adalah antifungal dan antiseptik.
Kata kunci: drug reaction with eosinophilia and systemic symptoms; faktor risiko; kandidiasis oral
ABSTRACT
Introduction: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare drug reaction but causes severe clinical reactions in the form of fever, skin eruptions, and involvement of internal organs. Medical therapy for DRESS patients in the form of high potent corticosteroids has a risk factor for oral candidiasis and systemic immune disorders. This case report aimed to describe the risk factors and management of oral candidiasis in DRESS patients. Case report: A 51-year-old male was treated for 14 days with a diagnosis of DRESS by the Department of Dermatology and Venereology of Hasan Sadikin Hospital, Bandung. Intravenous therapy administered was 20 grams/day of Dexamethasone, 3x1 ampoules/day of Vitamin K, 1x40 grams/day of Omeprazole, and 2x400 grams/day of Ciprofloxacin. Oral therapy was 1x10 grams/day of Cetirizine, 3x1 capsules/day of Curcuma, 1x1 tab/day of folic acid, 2x2 mg/day of Acetylcysteine, and 1x500 mg/day of Callos. The patient was then referred to the Department of Oral Medicine because of complaints of pain in the oral cavity, throat, and lips after hospitalisation for three days. History of recurrent thrush was denied. The patient never brushed his teeth during hospitalisation. The management of oral candidiasis was the administration of Nystatin in oral suspension with the dose of 4x200,000 IU/day, 0.12% Chlorhexidine digluconate, hyaluronic acid, 0.9% NaCl, and 2% topical Miconazole, and a mixture of 0.002% dexamethasone ointment, which was given related to lesions on the lips, and topically administered in the corner of the lips. Conclusion: The risk factors for oral candidiasis in DRESS patients are systemic use of corticosteroids, DRESS-related immune disorders, and poor oral hygiene. The management of oral candidiasis is antifungal and antiseptic.
Keywords: drug reaction with eosinophilia and systemic symptoms; oral candidiasis, risk factors
Keywords
Full Text:
PDFReferences
De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature. Indian J Dermatol. 2018;63(1):30-40. doi:10.4103/ijd.IJD_582_17
Patil A. Drug rash with eosinophilia and systemic symptoms, uncommon, and commonly missed. Int J Adv Med. 2019;6(4):1360–2.
Kardaun SH, Sekula P, Liss Y, Chu CY, Creamer D, Sidoroff A, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. British Journal of dermatology. 2013;169(5):1071–80.
Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS)/Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87(3):435-49. doi: 10.1590/s0365-05962012000300013. PMID: 22714760.
Omairi NEL, Abourazzak S, Chaouki S, Atmani S, Hida M. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review. Pan Afr Med J. 2014;18:9. Published 2014 May 2. DOI:10.11604/pamj.2014.18.9.3799
Choudhary S, Mcleod M, Torchia D, Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthet Dermatol. 2013;6(6):31–7.
Tomani M, Caridi C, Charlot C. Complicated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome History in a 14-Year-Old. J Case Reports. 2021;22:1–7.
Vila T, Sultan AS, Montelongo-jauregui D. Oral Candidiasis : A Disease of Opportunity. J Fungi. 2020;6:1–28.
Kragelund C, Reibel J, Pedersen AML. Oral Candidiasis and the Medically Compromised Patient. In: Oral pathology and Oral Medicine. Springer Link: online chapter book. 2016. p. 65–77.
Ericson-Neilsen W, Kaye AD. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J. 2014;14(2):203-7. PMID: 24940130; PMCID: PMC4052587.
Wood NH, Khammissa R, Meyerov R, Lemmer J, Feller L. Actinic cheilitis: A case report and a review of the literature. Eur J Dent. 2011;5(1):101–6.
Garcia-Cuesta C, Sarrion-Pérez MG, Bagán J V. Current treatment of oral candidiasis: A literature review. J Clin Exp Dent. 2014;6(5):e576–82.
Uzzaman A, Cho SH. Classification of hypersensitivity reactions. In: Allergy and Asthma Proceeding. East Providence: OceanSide Publication; 2012. p. 96–9.
Sharma A. Oral Candidiasis : An Opportunistic infection-A Review. Int J Appl Dent Sci. 2019;5(1):23–7.
Muzurovic S, Babajic E, Masic T, Smajic R, Selmanagic A. The relationship between oral hygiene and oral colonisation with Candida species. Med Arh. 2012;66(6):415–7.
Kiran MS, Vidya S, Aswal GS, Kumar V, Rai V. Systemic and Topical Steroids in the Management of Oral Mucosal Lesions. J Pharm Bioallied Sci. 2017;9(Suppl 1):S1-S3. DOI:10.4103/jpbs.JPBS_91_17
Monteiro DR, Silva S, Negri M, Gorup LF, de Camargo ER, Oliveira R, et al. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. Mycoses. 2013;56(6):672–80.
Kristiyaningrum, Indanah, Suwarto T. Efektivitas Penggunaan Larutan NaCl dibandingkan dengan D40% Terhadap Proses Penyembuhan Luka Ulkus DM di RSUD KUDUS. J Ilmu Keperawatan dan Kebidanan. 2013;4(2):52–8.
Coronado C. Clinical and microbiological diagnosis of oral candidiasis. Journal of Clinical and Experimental Dentistry. 2013;5(5):279-286.
DOI: https://doi.org/10.24198/jkg.v34i1.33531
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Jurnal Kedokteran Gigi Universitas Padjadjaran
INDEXING & PARTNERSHIP
Jurnal Kedokteran Gigi Universitas Padjadjaran dilisensikan di bawah Creative Commons Attribution 4.0 International License